2-[[4-[2-[4-[[4,6-Bis[4-[[[4,6-bis(carboxymethylamino)-1,3,5-triazin-2-yl]amino]carbamoyl]anilino]-1,3,5-triazin-2-yl]amino]benzoyl]hydrazinyl]-6-(carboxymethylamino)-1,3,5-triazin-2-yl]amino]acetic acid

InChIKey	`WXMUXNHNFVCNMU-UHFFFAOYSA-N`
Compound Name	2-[[4-[2-[4-[[4,6-Bis[4-[[[4,6-bis(carboxymethylamino)-1,3,5-triazin-2-yl]amino]carbamoyl]anilino]-1,3,5-triazin-2-yl]amino]benzoyl]hydrazinyl]-6-(carboxymethylamino)-1,3,5-triazin-2-yl]amino]acetic acid
Canonical SMILES	`O=C(O)CNc1nc(NCC(=O)O)nc(NNC(=O)c2ccc(Nc3nc(Nc4ccc(C(=O)NNc5nc(NCC(=O)O)nc(NCC(=O)O)n5)cc4)nc(Nc4ccc(C(=O)NNc5nc(NCC(=O)O)nc(NCC(=O)O)n5)cc4)n3)cc2)n1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	5
Pfam Stratification	Homologous
Avg pChEMBL	6.69
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P45452	MMP13	Homo sapiens	Human	PF00045 PF00413 PF01471	6.9	IC50	ChEMBL
P09238	MMP10	Homo sapiens	Human	PF00045 PF00413 PF01471	6.8	IC50	ChEMBL
P14780	MMP9	Homo sapiens	Human	PF00040 PF00045 PF00413	6.8	IC50	ChEMBL
P09237	MMP7	Homo sapiens	Human	PF00413 PF01471	6.7	IC50	ChEMBL
P08253	MMP2	Homo sapiens	Human	PF00040 PF00045 PF00413	6.2	IC50	ChEMBL